We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Schering Partners with ChemDiv in Medicinal Chemistry

News   Sep 15, 2005

 
Schering Partners with ChemDiv in Medicinal Chemistry
 
 
 

RELATED ARTICLES

Targeting Enzyme “Bottleneck” Reveals Novel Anticancer Drug Strategy

News

The enzyme ribonucleotide reductase is a bottleneck for cancer cell growth. Scientists have now identified a way of targeting ribonucleotide reductase that may avoid the toxicity of previous approaches, informing focused drug discovery efforts.

READ MORE

Compound Created to Block Therapeutic Target in Blood Cancer

News

Researchers have discovered a hyperactive cell signal that contributes to tumor growth in an aggressive blood cancer. The team has also developed an experimental therapeutic "UNC3810A" to block the signal and slow tumor growth.

READ MORE

Biosynthetic Pathway in Bacteria a Recipe for Drug Discovery

News

Microbes are the "master chefs" of the biomolecular world; collectively, they harbor the ability to produce a vast array of unknown substances, some of which may have therapeutic or other useful properties. In searching for useful products, a team of chemists have uncovered a whole new class of microbial recipes.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE